The ubiquitin-proteasome pathway in Huntington's disease

63Citations
Citations of this article
96Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The accumulation of mutant protein is a common feature of neurodegenerative disease. In Huntington's disease, a polyglutamine expansion in the huntingtin protein triggers neuronal toxicity. Accompanying neuronal death, mutant huntingtin aggregates in large macromolecular structures called inclusion bodies. The function of the machinery for intracellular protein degradation is linked to huntingtin toxicity and components of this machinery colocalize with inclusion bodies. An increasing body of evidence implicates the ubiquitin-proteasome pathway in the failure of cells to degrade mutant huntingtin. A number of potential mechanisms that link compromised ubiquitin-proteasome pathway function and neurodegeneration have been proposed and may offer opportunities for therapeutic intervention. ©2008 with author. Published by TheScientificWorld.

Cite

CITATION STYLE

APA

Mitra, S., & Finkbeiner, S. (2008, April 20). The ubiquitin-proteasome pathway in Huntington’s disease. TheScientificWorldJournal. https://doi.org/10.1100/tsw.2008.60

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free